AVGO
Broadcom Inc.Close $417.76EOD onlyThis page reflects AVGO options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
You are viewing an older report from April 2, 2026. A newer directional report is available for May 20, 2026.
View latest reportOutlook
Neutral-to-bullish with a strong pinning force toward $310-$320, though the gravitational pull has weakened slightly. Confidence: 8.5/10. Spot has rallied to $314.55, now much closer to near-term max pain levels, reducing the drift potential but maintaining a supportive, range-bound regime.
Conflicts: Spot is now near MP, reducing drift catalyst. Elevated IV (47.6%) adds premium but also tail risk.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+101.9M
DEX: +42.0M shares
Gamma flip: ~$250 (Approx — based on put OI concentration of 14,025)
NTM gamma: Gamma flip is far below at ~$250. The massive positive GEX means dealer hedging **dampens volatility** and **reinforces the current range**. A +2% move toward $321 would trigger dealer selling (resistance), a -2% move toward $308 would trigger dealer buying (support).
IV Analysis
IV vs VIX: IV 47.6% is very high (no VIX given, but context suggests elevated vol). Premium selling is strongly favored.
Term structure: Humped: Steep rise from 8.4% (0d) to 38.4% (4/10), then plateaus in the mid-40s. **Kink at 4/6 (26.5%) vs 4/8 (36.1%)** creates a ~10 vol-pt differential — a clear calendar spread opportunity.
Skew: Sell 4/8 $320C (IV ~36%) vs. buy 4/6 $320C (IV ~26%) for a reverse calendar to capture steep near-term vol decay.
Flow Analysis
Net premium: +$28.7M bullish; P/C Vol 0.79, P/C OI 1.16.
Directional prints: $327.50C 4/6 vol 1,726 vs OI 107 (16x) — likely bought calls targeting upside. $290P 4/6 vol 1,063 vs OI 113 (9x) — could be sold puts (bullish) or protective buys; sold is more consistent with bullish flow.
Unusual: Massive net negative premium at $380 strike (-$8.3M) due to put activity — likely a structural hedge/position, not near-term directional.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Iron condor | Moderate-Strong | $305/$300P x $325/$330C 4/17 (15 DTE). Short puts at 1w EM support ($303.02), short calls above MP ($320). | Break of pin range; defined risk. |
| Cash-secured put / put spread | Strong | Sell $310/$305 put spread 4/17. Collect premium below spot with pin support at $310 MP. | Spot collapses below $305. |
| Covered call | Moderate-Strong | Own stock, sell $330C 6/18 (77 DTE). Above near-term resistance, captures elevated IV. | Capped upside if stock rallies past $330. |
| Long calls | Moderate-Weak | Buy $320C 4/17, targeting MP drift. High IV is a significant headwind. | IV crush and failed pin drift. |
| Long puts / bear put spread | Weak | Avoid — contradicts bullish flow, positive GEX, and pin regime. | Fighting strong supportive gamma and flow. |
| Calendar/diagonal | Moderate-Strong | Reverse Call Calendar: Sell $320C 4/8 (IV ~36%), Buy $320C 4/6 (IV ~26%). Captures ~10 vol-pt decay. | Spot moves far from $320, hurting short gamma. |
| PMCC / LEAPS diagonal | Moderate | Buy Jan 2027 $300C (IV ~48%), sell monthly $330C against it. Leverages long-term bullish flow and high IV. | Capital intensive; near-term pin limits short call premium. |
| Short stock | Weak | Avoid — positive GEX and bullish flow create strong headwinds. | Squeeze toward MP and dealer buying on dips. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.